CSF1r Inhibitor

Our Platform delivers very potent, selective and novel CSF1r inhibitors series for peripheral and CNS disease.
This type of inhibitors is a clinical validated approach to treat solid cancer, can be promissing to treat inflammation (Rhumatoid Arthritis, Psoriasis, SLE) and neuroinflammation (Alzheimer, Parkinson, Hungtinton, MS).